{
    "abstract": "All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.",
    "author": "Alfredo Guillen-del-Castillo; Fernando Salvador; Arnau Monforte-Pallares; Benito Almirante; Simeon Eremiev; Adrian Sanchez-Montalva; Nuria Fernandez-Hidalgo; Abiu Sempere-Gonzalez; Juan Espinosa-Pereiro; Marta Miarons; Salvador Augustin; Julia Sampol; Andres Anton; Xavier Dura-Miralles; Julia Selares-Nadal; Santiago Perez-Hoyos; Pau Bosch-Nicolau",
    "date": 2020,
    "doi": "10.1101/2020.05.07.20094599",
    "identifiers": {
        "url": "http://medrxiv.org/cgi/content/short/2020.05.07.20094599"
    },
    "title": "Early outcomes of tocilizumab in adults hospitalized with severe COVID19. An initial report from the Vall dHebron COVID19 prospective cohort study.",
    "funding": [
        {
            "award-group": [],
            "funding-statement": "No specific funding was received for this study."
        }
    ]
}